Spencer S. Eccles Health Sciences Library, University of Utah
Abstract
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affects most frequently young overweight women. The NORDIC IIH treatment trial defined the value of acetazolamide and weight loss in the management of IIH. The goal of this study was to reflect upon our outcomes based upon our traditional strategy for managing patients and also to explore outcomes across a greater range of visual disability than was studied in the IIH treatment trial study